Home » Topics » BioWorld Science

BioWorld Science
RSS

Xarelto receives approval in the E.U. for the treatment of patients with artery disease

Aug. 27, 2018

EGFR tyrosine kinase inhibitor from UCLA crosses the blood-brain barrier

Aug. 27, 2018

Lawrence Livermore National Laboratory develops nerve agent antidote LLNL-02

Aug. 27, 2018

Koligo introduces Kyslecel to preserve insulin secretory capacity after total pancreatectomy

Aug. 27, 2018

Nilotinib improves biomarkers of Parkinson's disease in phase II study

Aug. 27, 2018

Unexpected asthma mechanism changes targeting calculus

Aug. 27, 2018

Brain-on-three-chips includes BBB

Aug. 27, 2018

Parkin, PINK keep inflammation pout of the red zone

Aug. 27, 2018

Kinase interplay prevents ALS

Aug. 27, 2018

FDA approves cobas EGFR Mutation Test v2 as companion diagnostic test with Iressa

Aug. 24, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...